Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
MRO, a leading clinical data workflow platform and the KLAS-rated No. 1 provider of release of information (ROI) solutions, announced the acquisition of Rockford, IL-based FIGmd, a leading provider of clinical, claims and quality data acquisition ...
read more
Wednesday, February 09, 2022
Humanigen, Inc. and Cenexi, a French CDMO, announced a collaboration aimed at making Cenexi a preferred supplier of lenzilumab in France and the European Union. The initial step of the collaboration includes the execution of a Master Supply Agreement...
read more
Monday, September 18, 2023
Astrea Bioseparations, a provider of bioseparation and purification technologies announced the expansion of its manufacturing and warehousing capabilities in the US. The increased capacity reflects growing demand for the Company’s chromatography ...
read more
Wednesday, March 20, 2024
Paradigm Clinical Research, a clinical research site business, announced the opening of its flagship clinic in San Diego, California, coinciding with the celebration of the company’s 15th anniversary.
read more
Aidoc announced the FDA has allowed the use of their cleared AI algorithms intended for adjunctive use in the detection of findings associated with COVID-19.
read more
Monday, December 14, 2020
Health Decisions and OncoBay Clinical announced a partnership to deliver specialized clinical development services for pharmaceutical and biotechnology companies developing therapeutics, medical devices, and diagnostics in oncology.
read more
The U.S. regulatory landscape has changed dramatically in 10 years. In 2003, the FDA finally resolved legal hurdles to the 505(b)(2) approval pathway, making it a practical alternative route for drug development. The same year, Ken Phelps and Ruth ...
read more
Duchesnay, a specialty pharma company with a long-standing commitment to women's health, has acquired exclusive U.S. and Canadian rights to market and distribute Osphena® (ospemifene) from Shionogi Inc. Osphena® is the only oral, non-hormonal ...
read more
CellCarta and Olink Proteomics AB announced a strategic collaboration to offer Olink® Target 96 & Target 48 to pharmaceutical and biotech customers, advancing targeted protein biomarker quantification in clinical studies.
read more
Wednesday, September 09, 2020
Brickell has the right to develop AnGes’ proprietary investigational adjuvanted plasmid DNA vaccine intended to prevent COVID-19.
read more
Bristol-Myers said Tuesday that federal regulators will help speed up development for one of its experimental HIV drugs.
read more
Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that Dr. M. James Barrett, Ph.D., has resigned from its ...
read more
Thursday, November 09, 2017
Recipharm will initiate a process with the intention of discontinuing manufacturing operations at its facilities in Stockholm and Höganäs, Sweden.
read more
Accelovance has signed a merger agreement with Linical, a CRO based in Asia in the fields of oncology, immunology, and neurology.
read more
ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, announced that March Biosciences has been awarded a $200,000 G-Rex® Grant. March Biosciences' G-Rex® Grant will be used to advance the manufacturing of...
read more